Elligo’s access to over 150 million diverse patients and their data takes research into the real world.

Elligo’s Transformative Model Is Changing the Clinical Research Paradigm

Expanding patient access to research as a care option, including a diverse patient population that is often underserved and underrepresented.

Read More

Providing the infrastructure, technology, personnel, and support required to easily and seamlessly integrate clinical research into your physician practice.

Read More

Accelerating clinical trial patient identification and enrollment through access to 150M+ diverse patients, which enables you to conduct more efficient, cost-effective research, and get your products to market faster.

Read More

Elligo Health Research® Has Brought Research as Care to Over 200 Clinical Trials

gilead
kaleido
orphomed
orphomed
oncternal
jazz
genomic
obseva
janssen
geneoscopy
geneoscopy
isofol
radius
progenity
precision
freenome
ironwood
novo nordisk
myriad
firma
finch
inovio
charleston
bristol-meyers
corrona
avillion
astellas
arena
urovant
urotronic
seres
velicept
veracyte
ucb
mycovia
boehringer
gsk
synteract
summit
parexel
merck
icon
enanta
biogen
biohaven
evofem
ferring
imv
mithra
pfizer
syneos
acadia
akcea
innovate
allergan
taris
ppd
pra
celgene
clinipace
kowa
novartis
sanofi
amgen
astra-zeneca
iqvia
covance
sermonix
medpace
lilly
grunenthal
bayer
dermasensor
abbvie
papivax
textured bg right

The Latest From Elligo

Article

Leveraging EHRs and Community Practices to Accelerate Patient-Focused Decentralized Clinical Trials

August 3, 2021

Read More